MS Bioworks
@msbioworks.bsky.social
390 followers 1.5K following 300 posts
We productized proteomics services and tranformed the field. Here to discuss all things proteomics and occasionally stir the pot :)
Posts Media Videos Starter Packs
Reposted by MS Bioworks
msbioworks.bsky.social
This is fantastic. Great job and good luck!
Reposted by MS Bioworks
julialmv.bsky.social
We are excited to open enrollment for the Long COVID Treatment Trial (LoCITT) soon!

We designed the first trial to be accessible & inclusive as possible. People across the US can participate from bed!

To sign up for the waitlist and/or watch our webinar recording, visit: longcovid.scripps.edu
Screenshot from webinar:
Title: one-slide summary
[LoCITT logo & thumbnail of me speaking]
We are planning a suite of digital trials to treat Long COVID
We expect the first one to launch this fall
In this first trial half of participants will receive placebo; this is essential for producing data that will be taken up by the medical community.
Our goal is to make the trials as accessible & inclusive as possible
We will conduct this work with the urgency that the public health crisis of Long COVID deserves
And we will include other infection-associated chronic conditions, whenever possible.
We will return personalized information to participants
Real-time wearable data, information generated from blood samples
To be notified when each trial launches, join the waitlist at longcovid.scripps.edu Overcoming trial design challenges

Table with parallel challenges & solutions:
Challenge: Heterogeneous presentation
Solution: Match eligibility criteria to intervention & Power trial to detect subgroup effects

Challenge: Don’t understand cause & effect
Solution: Conduct mechanistic trials that can help disentangle 

Challenge: Lack of biomarker
Solution: Utilize sensitive survey outcomes & wearable data

Challenge: Many are housebound/bedbound
Solution: Bring trials to participants
First trial size and metrics
Randomized, double-blind placebo controlled trial in 1,000 participants

Table of outcome types and metrics:
Primary: Fatigue Severity Scale (FSS)
Secondary: FUNCAP27, DSQ-PEM, EQ-5D-5L
Exploratory: Wearable data (step count, heart rate, variability, resting heart rate, max heart rate), demographics, medication compliance
Biosample (50 participants): 3 clinical labs, proteomics Ways LoCITT centers on participants

You can complete study activities from wherever you are
We work to minimize participant burden
Secondary outcomes were selected for validation for future trials
Our first user testers were 2 people with very severe symptoms
Thank you to Catherine Romatowski and a second anonymous tester!
Participants choose how they communicate with the study team
24/7 phone line for time-sensitive matters, video calls, emails, etc.
We share a letter to help coordinate with your health care provider(s)
We welcome caregivers to support you in completing study tasks
Reposted by MS Bioworks
elisafadda.bsky.social
Tomorrow is #ChemNobel day!! 🥳🥳 While we are all waiting eagerly for the announcement, my cat Salem suggest to you #chemsky friends some important reading to quench the nerves,

1) ACS important content: www.acs.org/pressroom/re...

And... 1/2 🧵
The Chemistry of Cats | Reactions Science Videos - American Chemical Society
A look at some of the key "meow-locules" that make up the chemistry of cats.
www.acs.org
Reposted by MS Bioworks
lindsaykpino.com
Still got our latest preprint bookmarked in an unread tab of your browser? We got you. @afederation.bsky.social presenting @talusbio.bsky.social's work-in-progress on Wednesday! 🧬 🖥️ 🧪 #MassSpectrometry #Proteomics
fnucleosome.bsky.social
🎃 🥁This Wednesday in our 1st session of spookiest month👻 at #FragileNucleosome seminar, we are excited to host @sanimr.bsky.social & Alex Federation!
Register here for upcoming session and the entire series:
us06web.zoom.us/webinar/regi...
msbioworks.bsky.social
What a difference a database makes. Curious the number of database entries are in ( ) Curious to see how these numbers change with the UniProt update.
msbioworks.bsky.social
The changes in UniProt, between release 2025_04 and 2026_02, will result in a change in the content and size of the database. The number of Reference Proteomes will increase by 36% (reflecting a 34% increase on species covered), while the number of proteins in UniProtKB can be decreased by 43%
Reposted by MS Bioworks
maxplanck.de
Huge congratulations to this year's winners of the #NobelPrize in Physiology or Medicine: Mary Brunkow, Fred Ramsdell & Shimon Sakaguchi! 🏆The trio's groundbreaking work on peripheral immune tolerance is paving the way for crucial new treatments for cancer & autoimmunity. 🧬
Nobel prize in medicine awarded to scientists for immune system research
Mary E Brunkow, Fred Ramsdell and Shimon Sakaguchi worked on how the immune system can be prevented from harming the body
www.theguardian.com
msbioworks.bsky.social
What's the state-of-the-art in DIA XL-MS? #Proteomics #TeamMassSpec
Reposted by MS Bioworks
royalsociety.org
“Jane Goodall was an amazing scientist who inspired people to see the natural world in a new way. She helped us to look at the animal kingdom with fresh eyes and with greater respect.
Reposted by MS Bioworks
phealthy.bsky.social
This is pretty crazy, study models millions of indirect hurricane deaths potentially driving/contributing to the life expectancy disparity in the US:

www.nature.com/articles/s41...
a, Total incidence of TCs on CONUS by month. Bar height is sum of average maximum wind speeds for all state-by-storm events. Colours correspond to decades. b, Stacked overlapping excess mortality responses to each storm for all of CONUS. Each storm response aggregates state-level responses nationally, accounting for state-level population and adaptation. Outline colours correspond to the decade when the TC occurred. The upper envelope is the total estimated mortality burden for CONUS resulting from all TCs occurring during the prior 172 months (see Supplementary Fig. 3). c, Official deaths directly resulting from TCs for each month according to NOAA National Hurricane Center and NOAA National Weather Service6,7. The y-axis scale is the same for b and c.
Reposted by MS Bioworks
thetnholler.bsky.social
And after 40 minutes of cringe-Thunderous applause from the generals!

Just kidding. Total silence. 👀 🦗 🦗
Reposted by MS Bioworks
michaelsteidel.bsky.social
Hey #TeamMassSpec,

Many non-human proteomics studies still search against taxon-filtered FASTAs.

❌ Redundant sequences
❌ Inflated search space
✅ Reference proteomes cut redundancy, improve annotation, and make results comparable.

👉 Time to move beyond taxon filters. #proteomics #massspec #uniprot
msbioworks.bsky.social
Woah! Good catch, thanks for sharing. It did feel like the protein entries had been ballooning.
Reposted by MS Bioworks
asbmb.bsky.social
Full circle moment!

While visiting ASBMB for a Maximizing Access Committee meeting, @garcialabms.bsky.social spotted one of his early JBC papers.
www.jbc.org/article/S002...

Do you remember the thrill of your early publications? Share below!
@asbmbjournals.bsky.social #asbmbJBC #TeamMassSpec
Ben Garcia stands in front of a bookcase lined with past printed issues of the Journal of Biological Chemistry, which have green covers and gold lettering. He is holding one of the journals open to his 2007 article "Organismal Differences in Post-translational Modifications in Histones H3 and H4."
msbioworks.bsky.social
For the longest time SwissProt Human was the go to, maybe five years ago UniProt Human became popular. Now, especially for plasma proteomics, I see folks searching any old crap to boost numbers. It's really quite sad.
Reposted by MS Bioworks
syncellinc.bsky.social
🌟 Meet Tina Chong, our Senior Applications Manager! She bridges customer goals with Microscoop workflows—helping uncover proteins that matter in cancer research.

#Proteomics #TeamSyncell